Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Oxford Lane Capital Corp. Provides September 8, 2025 Net Asset Value Update
-
SmartBrief Launches AI-Powered Behavioral Targeting to Unlock Precision Marketing for B2B Advertisers
-
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
-
Canyon Labs Elevates Leadership to Unite Sites and Strengthen Client Partnerships
-
2025 SHPE National Convention Brings 12,000 Attendees to Philadelphia for a STEM Career Fair, University Village, Leadership Workshops & More
-
IRS Cracks Down on Unreported Tip Income - Clear Start Tax Warns Service Industry Workers to Prepare for 2025 Changes
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
QFIA and Capvorth Partner to Build Cross-Border Compliance Practice Platform, Second Course Officially Launches
-
DPM Metals Completes Name Change from Dundee Precious Metals
-
Media Advisory: NobleAI to Showcase AI-Powered Innovation at Lubricant Expo Europe
-
BYD Clarifies Statements Made by Stellantis CEO Antonio Filosa
-
Tier One Silver Closes First Tranche of Previously Announced Upsized Private Placement
-
Hong Kong Cyclothon Returns on 30 November
-
Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT
-
M/I Homes, Inc. Announces Third Quarter Webcast
-
"National Step Family Day Is a Reminder for Blended Families to Protect Their Legal Rights"
-
OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b Prostate Cancer Clinical Trial Completes Last Visit
-
Saviynt Partners with St. Fox to Build a Scalable, Trusted Identity Ecosystem for India
-
THEON INTERNATIONAL launched in DSEI London 2025 the Production-Ready NYX-BiNOD, a U.S. Army Specification-Compliant Night Vision Binocular
-
Félix Bernard to Hold Autumn Private Auction in October
-
Ant Group’s AI Healthcare App AQ Users Reach 140 Million, 60% from Tier-three and Lower-Tier Cities
-
Spanish Translation of Best Practices for Repositories, Fifth Edition Now Available at https://www.isber.org/bpr
-
DesignRush Podcast #106 Uncovers 5 Lessons for Scaling Brands in 2025
-
Emperor Metals Announces Private Placement Increase to $10 Million
-
Applied Materials Announces Cash Dividend
-
Plato Gold Announces Results of Drill Program at Lolita Project, Santa Cruz, Argentina
-
Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring
-
Humanoid Global Welcomes B. Spencer Martin to its Investment Advisory Board
-
Brightview Senior Living Celebrates Ranking Number One on Fortune's Best Workplaces for Aging Services
-
Wellvana ACOs Save Medicare $327M, Helping Community Providers Deliver High-Quality Care
-
Equity Residential Declares Third Quarter Dividends
-
Caliber Appoints Peter Dorrius to its Crypto Advisory Board
-
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
-
REPEAT – Domestic Metals Provides Project Update for Ongoing Field Level Exploration at the Smart Creek Project
-
Nepra Foods Issues Letter from CEO
-
The Fresh Factory Secures US$4 Million Credit Facility
-
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
-
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
-
Toobit Integrates Binance Smart Chain (BSC) on DEX+, Expands On-Chain Trading Ecosystem
-
SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index
-
Bally’s Corporation Announces Amendments to Its Revolving Credit Facility
-
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
-
Xinhua Silk Road: 2025 Asian Rowing U-19&U-23 Championships held in NE. China's Shenyang
-
Form 8.3 - [Treatt PLC]
-
Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation mod
-
NuRAN Obtains Authorization for DRC Infrastructure License
-
Actor Jeff Bridges Reflects on Recovery, Family, and Hope in Blood Cancers & Disorders Campaign
-
Trinity Logistics Recognized Again for Excellence
-
Camtek Announces Pricing of Upsized Private Offering of $425 Million of 0.00% Convertible Senior Notes due 2030
-
FHLBank Chicago, IFF, Impact Seven, and Cinnaire Celebrate Groundbreaking of Trailview Cottages
